PEspeaks

Mar 06, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Merck KGaA has announced measures intended to reduce costs and increase efficiency to ensure the long-term success of its business model
Mar 05, 2012
Pharmaceutical Executive
Biotechs in Colorado, US, are enjoying a windfall of funding from Venture Capitalists who have to date invested $66.
Mar 02, 2012
Pharmaceutical Executive
The Supreme Court will open up deliberations on the constitutionality of three important parts of healthcare reform (HCR) this month
Mar 02, 2012
Pharmaceutical Executive
A couple of years ago I spoke at a Life Sciences Forum organized by Oracle. The audience was 100-percent life science and IT professionals, but I spoke about the magazine business.
Mar 01, 2012
Pharmaceutical Executive
GlaxoSmithKline is recalling 394,230 bottles containing its antihypertensive drug DynaCirc CR (isradipine) controlled-release tablets, according to a Feb. 22, 2012, FDA enforcement report
Feb 29, 2012
Pharmaceutical Executive
By admin
In 1983—with the help of Abbey Meyers and the drive she had to help her son (more on that here)—the Orphan Drug Act was passed to incentivize pharma to step up and play an active role in drug development for the 30 million children and adults in the U.S.
Feb 28, 2012
Pharmaceutical Executive
By admin
Patients, policymakers and pharmaceutical companies are uniting around rare diseases on the rarest of calendar days, presaging a leap forward in health outcomes and business opportunities.
Feb 24, 2012
Pharmaceutical Executive
With an all-important FDA decision on carfilzomib scheduled for July 27, Onyx hopes to graduate to the next stage of commercial success. For a feature-length profile of Onyx and CEO Tony Coles
Feb 23, 2012
Pharmaceutical Executive
So far, the creative approaches industry has taken to develop tamper-resistant and abuse-deterrent opioid drugs have been largely matched by the ingenuity of those users who manage to tamper with and abuse those same formulations.
Feb 23, 2012
Pharmaceutical Executive
Publicis Healthcare continues its expansion into Asia with this week’s announcement of its acquisition of U-Link Business Solutions (UBS), one of China’s leading agencies specializing in healthcare communications.
native1_300x100
lorem ipsum